iDose TR Administration in an Office-Based Surgery Setting

Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.

Inclusion Criteria: * Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT) Exclusion Criteria: * Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye * Active ocular infection or inflammation * History of hypersensitivity to travoprost or implant components * Recent ocular surgery * Uncontrolled systemic disease * Any condition preventing safe implantation